Skip Navigation


Annals of Oncology Advance Access originally published online on March 5, 2008
Annals of Oncology 2008 19(5):1019; doi:10.1093/annonc/mdn051
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/5/1019    most recent
mdn051v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ishiguro, H.
Right arrow Articles by Fukushima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishiguro, H.
Right arrow Articles by Fukushima, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letters to the editor

Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim

The first 10% of the full text of this article appears below.

In the dose-dense (DD) chemotherapy trial result reported by Piedbois et al. [1], they found more hematological toxicity leading to treatment discontinuation in the pegfilgrastim supported DD chemotherapy arm. The manufacturer's product information for pegfilgrastim indicates that it should be used once per chemotherapy cycle and should not . . . [Full Text of this Article]

H. Ishiguro1,*, T. Kitano2, H. Yoshibayashi3, M. Toi3, T. Ueno3, H. Yasuda1, K. Yanagihara2, C. L. Garbo4 and M. Fukushima1

1 Department of Clinical Trial Management/Outpatient Oncology Unit, Translational Research Center
2 Department of Translational Clinical Oncology/Outpatient Oncology Unit
3 Department of Breast Surgery, Kyoto University Hospital, Kyoto 606-8507, Japan
4 Ithaca Medical Group, Ithaca, NY 14850, USA

* (E-mail: hishimd@kuhp.kyoto-u.ac.jp)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?